Core Viewpoint - The joint release of the "Implementation Opinions on Promoting the Innovative Development of Brain-Machine Interface Industry" aims to accelerate the research and development of implantable devices and enhance the application of brain-machine interfaces across various sectors, including industrial manufacturing and healthcare [1][2]. Group 1: Development Goals - By 2027, breakthroughs in key technologies related to brain-machine interfaces are expected, establishing an advanced technical, industrial, and standard system [2]. - The industry is projected to grow significantly, with the creation of 2 to 3 industrial development clusters and the emergence of new scenarios, models, and business formats [2]. - By 2030, the innovation capability of the brain-machine interface industry is anticipated to be significantly enhanced, fostering 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [2]. Group 2: Product Development - The focus is on accelerating the R&D of implantable devices, including high-density neural recording sensors and ultra-low power implantable chips, to improve control precision and response speed [2][3]. - Non-invasive devices are also being promoted, with innovations in product forms such as adhesive, ear, and head-mounted devices, aiming for lightweight, high-speed, and low-power characteristics [3]. - Development of auxiliary devices is encouraged, integrating brain signals with other physiological signals to enhance interaction control and perception assessment accuracy [3]. Group 3: Policy Support and Market Impact - The opinions emphasize strengthening technological breakthroughs and application demonstrations, with increased investment from national funds to support the industry [4]. - Specific pricing for invasive brain-machine interface procedures has been established, with insertion fees set at 6,580 yuan and removal fees at 3,150 yuan, which is expected to stimulate market growth [4]. - The successful initiation of clinical trials for implantable brain-machine interfaces in China marks a significant milestone, positioning the country as the second globally to enter this phase after the United States [4]. Group 4: Industry Collaboration - The development of brain science is highlighted as a typical case of interdisciplinary collaboration, requiring cooperation among technology developers, clinical institutions, capital, and government [5]. - Startups in this field are advised to balance short-term survival needs with long-term innovation goals to avoid compromising core technology development due to market pressures [5].

记者丨 冉黎黎 编辑丨周上祺 近日，工业和信息化部、国家发展改革委、教育部、国家卫生健康委、国务院国资委、中国科 学院、国家药监局等七部门印发《关于推动脑机接口产业创新发展的实施意见》（以下简称 《实施意见》）。 《实施意见》提出，到2027年，脑机接口关键技术取得突破，初步建立先进的技术体系、 产业体系和标准体系。电极、芯片和整机产品性能达到国际先进水平，脑机接口产品在工 业制造、医疗健康、生活消费等加快应用。产业规模不断壮大，打造2至3个产业发展集聚 区，开拓一批新场景、新模式、新业态。 到2030年，脑机接口产业创新能力显著提升，形成安全可靠的产业体系，培育2至3家有全 球影响力的领军企业和一批专精特新中小企业，构建具有国际竞争力的产业生态，综合实 力迈入世界前列。 记者注意到，《实施意见》提出了 五大重点任务，包括加强基础软硬件攻关、打造高性能产 品、推动技术成果应用、壮大创新主体、提升产业支撑能力 。《实施意见》同时列出了 三个 重点工程，即核心软硬件强基工程、整机精品工程、应用拓展工程 。 出品丨21财经客户端 21世纪经济报道 编辑丨金珊 实习生郑莹莹 6500亿巨无霸并购诞生！A股重组五大新趋 ...

Core Viewpoint - The article highlights the significant policy support for the brain-computer interface (BCI) industry, with a focus on the implementation opinions released by multiple government departments aimed at fostering innovation and development in this sector by 2027 [1][2]. Summary by Sections Policy Implementation - On August 7, a joint implementation opinion was released by several government bodies, outlining 17 specific measures to promote the innovation and development of the BCI industry [2]. - The opinion sets a target for breakthroughs in key BCI technologies by 2027, establishing advanced technical, industrial, and standard systems [4]. Technological Development Goals - By 2027, the performance of electrodes, chips, and complete products is expected to reach international advanced levels, with applications in industrial manufacturing, healthcare, and consumer life accelerating [4]. - By 2030, the BCI industry is anticipated to significantly enhance its innovation capabilities, nurturing 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [4]. Product Innovation - The implementation opinion emphasizes the need for high-performance products, including breakthroughs in implantable devices and the development of new product forms such as adhesive, ear, and clip-on devices [4][5]. - There is a focus on developing high-channel, high-speed brain signal acquisition chips and auxiliary devices that integrate multiple physiological signals to improve interaction control and perception assessment accuracy [5]. Industry Growth and Support - The opinion encourages the growth of leading enterprises in the BCI field and the formation of industry innovation consortia, supporting the cultivation of technology-driven small and medium enterprises [5]. - The BCI industry is expected to receive substantial support from the government, with new pricing mechanisms for medical devices related to BCI technology being established [7]. Market Potential - The global BCI market is projected to reach approximately $7 billion by 2030, with a compound annual growth rate (CAGR) of 16.4% from 2025 to 2030 [8]. - The domestic BCI market is expected to grow significantly, with a market size of 1.73 billion yuan in 2023, reflecting an increase of over 5% compared to 2020 [8]. - By 2040, the Chinese BCI market is forecasted to exceed 120 billion yuan, with an annual growth rate of 26% [8].

Investment Rating - The industry investment rating is "Positive" (maintained) [3][6] Core Insights - Recent policies from seven departments in China are aimed at stimulating the brain-computer interface (BCI) industry, encouraging commercialization through local incentives and medical insurance integration [2][4] - The overall goal is to achieve breakthroughs in key technologies by 2027, establish advanced technical, industrial, and standard systems, and significantly enhance innovation capabilities by 2030, fostering globally influential leading enterprises [4] - The report suggests actively monitoring companies within the BCI industry chain, including both upstream hardware/software and downstream medical solution providers [2][4] Summary by Sections Investment Suggestions - Companies to watch in the upstream hardware/software sector include: Entropy Technology, iFlytek, Yanshan Technology, Zhongke Information, Dongfang Zhongke, Yingqu Technology, Nanjing Panda, Lihe Science and Technology, BYD Electronics [2] - In the downstream medical solutions sector, notable companies are: Aipeng Medical, Xiangyu Medical, Chengyitong, Ruimaite, Weisi Medical, Innovation Medical, Sanbo Neuroscience [2] Policy and Development Goals - By 2027, the BCI industry aims to achieve key technological breakthroughs, with products reaching international advanced levels and expanding applications in industrial manufacturing, healthcare, and consumer life [4] - By 2030, the goal is to cultivate 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises, establishing a competitive industrial ecosystem [4] Technical Advancements - Focus on enhancing brain signal sensing capabilities through innovative materials and processes, developing high-performance, low-power brain-machine chips, and integrating AI into decoding processes [4] - Accelerate the development of high-performance products, including both implantable and non-implantable devices, to improve control precision and response speed [4]

出品丨深网·腾讯新闻小满工作室 "春节后我注意到一个变化，"强脑科技（BrainCo）创始人韩璧丞说，"很多同事的电脑屏保，悄然从马斯克换成了DeepSeek创始人梁文锋。" DeepSeek的爆火，让梁文锋的故事刷屏。低调、谦逊和不事张扬的形象，在流量的狂欢中淬炼出独特光芒，却意外成就了这个时代最稀缺的英雄叙事： 用技术纯粹地改变世界。跟着梁文锋一起爆火的，还有杭州的"六小龙"。 位于余杭区文一西路的强脑科技参展区每日都人潮涌动——投资人、供应商、各地产业基金、政府部门纷至沓来；滨江区宇树科技大厦前同样排起长 队……无一例外，几家公司的门口都有一条温馨提示："没有付费参访服务！谨防受骗！" 来源：深网腾讯新闻 图： 创业初期，韩璧丞在波士顿的地下室做了一个机器人，可通过意识来对它控制。 文丨薛芳编辑丨张睿 半年光阴流转，这场"科技朝圣热"，还在持续。涌动的人群，他们朝圣的圣殿正在从硅谷转向本土。昔日，硅谷的光芒从惠普车库的微光燃起，直至 OpenAI 推开星际之门；而今，本土技术英雄登上了偶像神坛。 身处风暴中心的韩璧丞，把自己剥离于聚光灯之外。"我80%的时间仍在产品研发上，"他语气笃定。正是这份专注，使 ...

Group 1: Market Overview - 22 stocks had a closing order amount exceeding 1 billion yuan, with Tianyu Shuke leading at 2.95 billion yuan [2] - The top three stocks by closing order volume were Jihua Group, Tianyu Shuke, and Jishi Media, with volumes of 418,600 hands, 396,600 hands, and 323,700 hands respectively [2] - Stocks with consecutive limit-up days included *ST Dongjing and *ST Yushun with 5 consecutive days, while Beiwai Technology, Furi Electronics, and Guoji Precision achieved 4 consecutive days [2] Group 2: Company Performance - Tianyu Shuke is expected to achieve a net profit attributable to shareholders of 18 million to 26 million yuan in the first half of the year, marking a turnaround from losses [2] - The company reported growth in data traffic business and implemented cost-reduction measures positively impacting performance [2] - Ningbo Yunsheng anticipates a net profit of 90 million to 135 million yuan for the first half of 2025, representing a year-on-year growth of 133.55% to 250.33% [3] Group 3: Industry Insights - The rare earth permanent magnet sector saw stocks like Zhenghai Magnetic Materials and Ningbo Yunsheng hitting the limit-up [3] - The semiconductor sector had stocks such as Fumanwei and Dongxin Co. also reaching limit-up, with Fumanwei confirming normal shipments of 5G RF chips [4][5] - The brain-computer interface sector is indirectly engaged by companies like Jihua Group and Innovation Medical through partnerships, although they do not directly develop the technology [6] Group 4: Investment Trends - The top net buying stocks on the Dragon and Tiger list included Shuo Beid, Dongxin Peace, and Lide Man, with net buying amounts of 533 million yuan, 245 million yuan, and 214 million yuan respectively [7] - Institutional net buying was led by Dongfang Precision and Dawi Co., with amounts of 161 million yuan and 57.87 million yuan respectively [7]

Core Viewpoint - The implementation opinions issued by seven departments aim to promote the innovation and development of the brain-computer interface (BCI) industry, targeting significant technological breakthroughs by 2027 and establishing a competitive global industry ecosystem by 2030 [1][3]. Summary by Relevant Sections Key Tasks - The implementation opinions outline five key tasks: strengthening foundational hardware and software, creating high-performance products, promoting the application of technological achievements, expanding innovative entities, and enhancing industrial support capabilities [1][2]. Key Projects - Three major projects are highlighted: core hardware and software foundational projects, high-quality complete machine projects, and application expansion projects [1][2]. Technological Development - Emphasis is placed on innovating brain signal sensing components, developing various types of implantable electrodes, and enhancing the stability and reliability of materials [2]. - The development of high-performance products includes accelerating breakthroughs in implantable devices and promoting the mass production of non-implantable devices with innovative forms such as adhesive, ear, and head-mounted interfaces [2]. Application Expansion - The implementation opinions stress the importance of promoting industrial innovation results and enhancing testing and pilot capabilities, particularly in medical health applications targeting neurodegenerative and mental disorders [3]. - The BCI technology aims to establish an information channel between the brain and machines, facilitating the integration of biological and machine intelligence [3]. Market Potential - The global market for BCI medical applications is projected to reach $40 billion by 2030 and $145 billion by 2040, indicating significant growth potential [3]. - In China, the BCI market is expected to grow from 3.2 billion yuan in 2024 to 5.58 billion yuan by 2027, with a growth rate of 20% [4]. Policy Support - Since 2025, various regions have released policies to seize global BCI development opportunities, including plans to establish demonstration zones for BCI industry development by 2030 [4].

Market Overview - The market showed a significant structural differentiation with 2117 stocks rising, indicating a typical "80/20" distribution where fewer stocks are driving gains [6][7] - The trading volume reached 1.83 trillion yuan, an increase of 5.27%, but did not surpass the critical threshold of 1.9 trillion yuan, suggesting caution as a drop below 1.7 trillion yuan may test the 3600-point support level [8] Sector Performance - The rare earth permanent magnet sector experienced a surge in the afternoon, while sectors such as pharmaceuticals faced widespread declines and military stocks mostly adjusted [7] - There was a notable divergence between heavyweight stocks and growth stocks, with small and mid-cap stocks becoming more active [8] Fund Flows - There was a net outflow of funds from institutional investors, while retail investors showed a net inflow, reflecting a contrasting sentiment in the market [9] - Institutions are adopting a "policy-driven structural adjustment" approach, remaining cautious about high-volatility themes driven by leveraged funds, indicating a more prudent adjustment pace compared to previous days [10] Investor Sentiment - Retail investors are exhibiting extreme anxiety in a differentiated market, with a wave of small-cap stocks hitting the limit up, attracting significant follow-up buying, while sectors like photovoltaics continue to decline, leading to a "making money on the index but not on stocks" effect [10]

Core Viewpoint - The article discusses the implementation opinions released by various Chinese government agencies aimed at promoting the innovation and development of the brain-computer interface (BCI) industry, with specific goals set for 2027 and 2030 [2][3]. Group 1: Goals and Timeline - By 2027, breakthroughs in key BCI technologies are expected, establishing an advanced technical, industrial, and standard system, with product performance reaching international advanced levels [3]. - The BCI industry is projected to grow significantly, creating 2 to 3 industrial development clusters and exploring new scenarios, models, and business formats [3]. - By 2030, the innovation capability of the BCI industry is anticipated to be significantly enhanced, forming a safe and reliable industrial system with 2 to 3 globally influential leading enterprises and a number of specialized small and medium-sized enterprises [3]. Group 2: Key Technology Breakthroughs - The implementation opinions emphasize the need to break through key BCI chips, including the development of high-precision surgical robots for implantable BCIs [4][6]. - Development of auxiliary devices is highlighted, focusing on high-channel, high-speed brain signal acquisition chips to enhance signal collection and amplification capabilities [4]. - The need for ultra-low power, high-speed, and highly reliable communication chips is stressed to improve brain signal transmission and anti-interference capabilities [4]. Group 3: Multimodal Signal Integration - The article mentions the development of auxiliary physiological signal devices that integrate brain signals with electromyography, electrooculography, electrocardiography, and near-infrared signals to improve interaction control and sensory assessment accuracy [6]. - The focus is on achieving sub-micron precision control and dynamic adjustment technology for surgical robots, enhancing real-time imaging and 3D reconstruction capabilities [6].

8月7日，智通财经获悉，美国血管介入脑机接口企业Synchron近日首次公开演示，植入血管介入脑机接 口系统的渐冻症患者，凭借意念便可以操控iPhone、iPad等，无需肢体动作或语音指令。这标志着苹果 公司将脑信号识别作为一种与触摸、键盘和语音并列的原生输入方式。 前中国内地首富陈天桥在2021年便已完成对Synchron的投资。陈天桥曾表示，"大脑是人类最后的疆 域，也是最具挑战性的研究领域。我们相信，通过对Synchron等前沿技术公司的投资，能够加速脑科学 与人工智能的融合发展。" 目前，Synchron已在多项临床试验中取得进展，在美国让6名患者的大脑运动皮层实现了精确部署和覆 盖，让其通过意念来操作电子设备发送电子邮件、网上购物和社交媒体互动等。 ...